Keyword Search
Legend:
CC = Colorado Convention Center H = Hyatt Regency Denver at Colorado Convention Center
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Estimand returned 6 record(s)
|
|
Wednesday, 07/31/2019
|
Estimand Framework in Oncology Drug Development – Impact and Opportunities
Evgeny Degtyarev, Novartis ; Kaspar Rufibach, F. Hoffmann-La Roche; Jonathan Siegel, Bayer HealthCare Pharmaceuticals Inc.; Viktoriya Stalbovskaya, Merus; Steven Sun, J&J
10:35 AM
|
Sensitivity Analysis Vs Supportive Analysis Under Estimand Framework: a Case Study in Hematological Malignancies
Steven Sun, J&J; Hans-Jochen Weber, Novartis; Marie-Laure Casadebaig, Celgene; Emily Butler, GlaxoSmithKline; Satrajit Roychoudhury, Pfizer Inc ; Kaspar Rufibach, F. Hoffmann-La Roche; Viktoriya Stalbovskaya, Merus
11:15 AM
|
Assessing the Ratio of Means as a Causal Estimand in Clinical Endpoint Bioequivalence Studies in the Presence of Intercurrent Events
Yiyue Lou, University of Iowa College of Public Health; Michael P. Jones, University of Iowa College of Public Health; Wanjie Sun, FDA
11:20 AM
|
Estimand Framework – Are We Asking the Right Questions? a Case Study in the Solid Tumor Setting
Michelle Casey , Pfizer; Evgeny Degtyarev, Novartis ; Maria Jose Lechuga, Pfizer, Inc.; Paola Aimone, Novartis Pharma AG; Feng Feng Liu, AstraZeneca; Viktoriya Stalbovskaya, Merus; Rui Tang, Servier; Emily Butler, GlaxoSmithKline; Oliver Sailer, Boehringer Ingelheim Pharma GmbH & Co
11:35 AM
|
|
|
